Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dilts

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Medicine|June 8, 2010
US cancer trials may go the way of the OldsmobileDavid Dilts
JAMA|February 20, 2002
Research as a quality improvement activityPaul V Miles, John W Bingham, David Dilts
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2008
Patients with cancer and e-mail: implications for clinical communicationDavid Dilts, Sheila H Ridner, Alejandro Franco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
A Randomized Controlled Trial of an Additional Funding Intervention to Improve Clinical Trial EnrollmentCatriona Parker, Raymond Snyder, Michael Jefford, et al.
Journal of Registry Management|September 7, 2019
Quality Assessment of Tumor Size Data Collection for Pancreatic and Breast Cancer in SEERRebecca Ehrenkranz, Clara Lam, Valentina I Petkov, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
Computerized provider order entry in the emergency department: pilot evaluation of a return on investment analysis instrumentJill K Piasecki, Elizabeth Calhoun, Jodi Engelberg, et al.
Expert Review of Neurotherapeutics|December 27, 2014
Charting a path toward combination therapy for Alzheimer's diseaseDiane Stephenson, Dan Perry, Cynthia Bens, et al.
Expert Review of Neurotherapeutics|February 25, 2015
Building a roadmap for developing combination therapies for Alzheimer's diseaseDaniel Perry, Reisa Sperling, Russell Katz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug developmentDouglas Yee, Tufia Haddad, Kathy Albain, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Medicine|June 8, 2010
US cancer trials may go the way of the OldsmobileDavid Dilts
JAMA|February 20, 2002
Research as a quality improvement activityPaul V Miles, John W Bingham, David Dilts
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2008
Patients with cancer and e-mail: implications for clinical communicationDavid Dilts, Sheila H Ridner, Alejandro Franco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
A Randomized Controlled Trial of an Additional Funding Intervention to Improve Clinical Trial EnrollmentCatriona Parker, Raymond Snyder, Michael Jefford, et al.
Journal of Registry Management|September 7, 2019
Quality Assessment of Tumor Size Data Collection for Pancreatic and Breast Cancer in SEERRebecca Ehrenkranz, Clara Lam, Valentina I Petkov, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
Computerized provider order entry in the emergency department: pilot evaluation of a return on investment analysis instrumentJill K Piasecki, Elizabeth Calhoun, Jodi Engelberg, et al.
Expert Review of Neurotherapeutics|December 27, 2014
Charting a path toward combination therapy for Alzheimer's diseaseDiane Stephenson, Dan Perry, Cynthia Bens, et al.
Expert Review of Neurotherapeutics|February 25, 2015
Building a roadmap for developing combination therapies for Alzheimer's diseaseDaniel Perry, Reisa Sperling, Russell Katz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug developmentDouglas Yee, Tufia Haddad, Kathy Albain, et al.
Pageof 1